CLINICAL_TRIALS
trial_result
· 2024-08-09
Clinical Trial Update: Eptinezumab in Participants With Episodic Cluster Headache [Phase 3]
Summary
Phase 3 trial results for eptinezumab in episodic cluster headache have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Cluster Headache, Episodic | Phase 3 | Status: COMPLETED | Results posted: 2024-08-09